| 1. |
Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest, 2010, 137(5): 1164-1171.
|
| 2. |
夏瑜, 王宇翀, 薛春雨. 血管肉瘤的研究進展. 中國美容整形外科雜志, 2020, 31(4): 227-229.
|
| 3. |
Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol, 2018, 30(2): 107-112.
|
| 4. |
王漢萍, 施舉紅, 王文澤, 等. 以彌漫性肺泡出血為首發表現的肺轉移性血管肉瘤九例分析. 中華內科雜志, 2018, 57(8): 582-587.
|
| 5. |
Chen MQ, Lu WL, Wu SG, et al. Metagenomic next-generation sequencing in the diagnosis of leptospirosis presenting as severe diffuse alveolar hemorrhage: a case report and literature review. BMC Infect Dis, 2021, 21(1): 1230.
|
| 6. |
Park MS. Diffuse alveolar hemorrhage. Tuberc Respir Dis (Seoul), 2013, 74(4): 151-162.
|
| 7. |
de Prost N, Parrot A, Picard C, et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J, 2010, 35(6): 1303-1311.
|
| 8. |
陳光星, 董怡, 鞠中斌. 彌漫性結締組織病并發彌漫性肺泡出血32例臨床分析. 中華內科雜志, 2008, 47(5): 362-365.
|
| 9. |
辛慶紅, 張文博, 李繼成, 等. 17例彌漫性肺泡出血臨床分析. 中國呼吸與危重監護雜志, 2010, 9(6): 624-626.
|
| 10. |
方芳, 李燕明, 胡松濤, 等. 彌漫性肺泡出血的臨床和病理學特征. 中華醫學雜志, 2016, 96(2): 108-112.
|
| 11. |
薛曉艷, 徐鈺, 陳永立, 等. 彌漫性肺泡出血31例臨床分析. 中國急救醫學, 2013, 33(3): 231-234.
|
| 12. |
沈吉林, 謝興宇. 感染相關性彌漫性肺泡出血綜合征1例報告. 貴州醫藥, 2018, 42(2): 224-225.
|
| 13. |
阮航, 簡竹, 王迎難, 等. 彌漫性肺泡出血. 中華結核和呼吸雜志, 2021, 44(11): 1019-1020.
|
| 14. |
劉毅, 鄭培浩, 岑堅, 等. 21例繼發于血液系統疾病的彌漫性肺泡出血分析. 解放軍醫學院學報, 2015, 36(5): 447-450.
|
| 15. |
Higo H, Suzaki N, Nagata T, et al. Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage. Respirol Case Rep, 2020, 8(3): e540.
|
| 16. |
Lichtenberger JP 3rd, Digumarthy SR, Abbott GF, et al. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol, 2014, 43(3): 128-139.
|
| 17. |
翟吉良, 張保中, 唐璜. 成人Kasabach-Merritt綜合征1例報道. 中華骨與關節外科雜志, 2015, 8(5): 444-446.
|
| 18. |
Florou V, Wilky BA. Current management of angiosarcoma: recent advances and lessons from the past. Curr Treat Options Oncol, 2021, 22(7): 61.
|
| 19. |
龔毓賓, 孫斌, 雷紅召, 等. Kasabach-Merritt現象的研究進展和治療. 中華實用兒科臨床雜志, 2014, 29(10): 789-791.
|
| 20. |
Yao W, Li KL, Qin ZP, et al. Standards of care for Kasabach-Merritt phenomenon in China. World J Pediatr, 2021, 17(2): 123-130.
|
| 21. |
Mahajan P, Margolin J, Iacobas I. Kasabach-Merritt phenomenon: classic presentation and management options. Clin Med Insights Blood Disord, 2017, 10: 1179545X17699849X.
|
| 22. |
Young RJ, Natukunda A, Litière S, et al. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Eur J Cancer, 2014, 50(18): 3178-3186.
|
| 23. |
周江元, 楊開穎, 彭素華, 等. 西羅莫司聯合潑尼松治療卡波西樣血管內皮瘤伴Kasabach-Merritt現象初探. 中華皮膚科雜志, 2020, 53(7): 514-518.
|
